• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORATION LACRIFAST; LACRIMAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORATION LACRIFAST; LACRIMAL STENT Back to Search Results
Catalog Number LF2-R105
Device Problems Material Separation (1562); Use of Device Problem (1670); Device Handling Problem (3265)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 04/10/2017
Event Type  malfunction  
Manufacturer Narrative
-the concerned device "lacrifast" is not distributed in us under this device name, but is identical to the device "lacriflow lacrimal stent" distributed in us under 510(k) # k120886.- the actual device used was not returned.The ring's whereabouts was not confirmed during the procedure in this eye clinic, and accordingly, the missing stainless steel ring might have been remaining in the patient body.- the device history record (dhr) of the lacrifast with lot no.Kp126196 was reviewed and no nonconformity or abnormality was found in its manufacturing processes.The device met its material, assembling and product specifications.- as a possible cause of dropping off the stainless steel ring during the use, we speculate as follows: when the doctor tried to decannulate the sheath to place this device in the patient's lacrimal duct by the g-sgi technique, an excessive mechanical force was loaded to the ring mounted portion, and the ring with the bougie penetrated out of the tip of the tube.
 
Event Description
This device (lacrifast) was employed to treat the epiphora due to lacrimal duct obstruction of a female patient.The doctor pre-opened the lacrimal duct by using a sheath.Then, he inserted one of the pair of lacrimal duct tubes into the sheath, that was pre-inserted in the lacrimal duct, by using the g-sgi (goto-sheath guided intubation) technique.While decannulating the sheath from the lacrimal duct, he felt a strong resistance.He retrieved the sheath and lacrifast out of the patient's lacrimal duct, and found the stainless steel ring mounted in the tip of the tube was missing.He used another lacrifast to complete the operation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LACRIFAST
Type of Device
LACRIMAL STENT
Manufacturer (Section D)
KANEKA CORPORATION
2-3-18
nakanoshima, kita-ku
osaka, osaka 530-8 288
JA  530-8288
Manufacturer Contact
kazuhiko inoue
2-3-18
nakanoshima,kita-ku
osaka, osaka 530-8-288,
JA   530-8288,
31814120
MDR Report Key6515164
MDR Text Key73457210
Report Number9614654-2017-00005
Device Sequence Number1
Product Code OKS
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/24/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2019
Device Catalogue NumberLF2-R105
Device Lot NumberKP126196
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/13/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-